Poor anticoagulation relates to extended access times for cardioversion and is associated with long-term major cardiac and cerebrovascular events
Patients undergoing elective electrical cardioversion (ECV) for atrial fibrillation have a temporarily increased risk of thromboembolism. Current guidelines recommend adequate anticoagulation for ≥3 consecutive weeks precardioversion, i.e. consecutive INR values 2.0–3.0 in patients with vitamin K an...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Erküner, Ömer [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016 |
|---|
| Umfang: |
5 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Metabolic effects of goat milk yogurt supplemented with yacon flour in rats on high-fat diet - Fabersani, Emanuel ELSEVIER, 2018, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:225 ; year:2016 ; day:15 ; month:12 ; pages:337-341 ; extent:5 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ijcard.2016.10.018 |
|---|
| Katalog-ID: |
ELV013904280 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV013904280 | ||
| 003 | DE-627 | ||
| 005 | 20230623111512.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijcard.2016.10.018 |2 doi | |
| 028 | 5 | 2 | |a GBVA2016006000027.pica |
| 035 | |a (DE-627)ELV013904280 | ||
| 035 | |a (ELSEVIER)S0167-5273(16)32820-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 630 |a 640 |a 610 |q VZ |
| 100 | 1 | |a Erküner, Ömer |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Poor anticoagulation relates to extended access times for cardioversion and is associated with long-term major cardiac and cerebrovascular events |
| 264 | 1 | |c 2016 | |
| 300 | |a 5 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Patients undergoing elective electrical cardioversion (ECV) for atrial fibrillation have a temporarily increased risk of thromboembolism. Current guidelines recommend adequate anticoagulation for ≥3 consecutive weeks precardioversion, i.e. consecutive INR values 2.0–3.0 in patients with vitamin K antagonists (VKA). We aimed to evaluate the occurrence and impact of subtherapeutic INRs precardioversion and to study factors associated with these unwanted fluctuations. | ||
| 700 | 1 | |a Claessen, Roy |4 oth | |
| 700 | 1 | |a Pisters, Ron |4 oth | |
| 700 | 1 | |a Schulmer, Germaine |4 oth | |
| 700 | 1 | |a Ramaekers, Roos |4 oth | |
| 700 | 1 | |a Sonneveld, Laura |4 oth | |
| 700 | 1 | |a Dudink, Elton |4 oth | |
| 700 | 1 | |a Lankveld, Theo |4 oth | |
| 700 | 1 | |a Limantoro, Ione |4 oth | |
| 700 | 1 | |a Weijs, Bob |4 oth | |
| 700 | 1 | |a Pison, Laurent |4 oth | |
| 700 | 1 | |a Blaauw, Yuri |4 oth | |
| 700 | 1 | |a de Vos, Cees B |4 oth | |
| 700 | 1 | |a Crijns, Harry JGM |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Fabersani, Emanuel ELSEVIER |t Metabolic effects of goat milk yogurt supplemented with yacon flour in rats on high-fat diet |d 2018 |g Amsterdam [u.a.] |w (DE-627)ELV000849189 |
| 773 | 1 | 8 | |g volume:225 |g year:2016 |g day:15 |g month:12 |g pages:337-341 |g extent:5 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ijcard.2016.10.018 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 225 |j 2016 |b 15 |c 1215 |h 337-341 |g 5 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
ö e öe |
|---|---|
| matchkey_str |
erknermerclaessenroypistersronschulmerge:2016----:orniogltorltsoxeddcesiefradoesoadssoitdihogema |
| hierarchy_sort_str |
2016 |
| publishDate |
2016 |
| allfields |
10.1016/j.ijcard.2016.10.018 doi GBVA2016006000027.pica (DE-627)ELV013904280 (ELSEVIER)S0167-5273(16)32820-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 630 640 610 VZ Erküner, Ömer verfasserin aut Poor anticoagulation relates to extended access times for cardioversion and is associated with long-term major cardiac and cerebrovascular events 2016 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Patients undergoing elective electrical cardioversion (ECV) for atrial fibrillation have a temporarily increased risk of thromboembolism. Current guidelines recommend adequate anticoagulation for ≥3 consecutive weeks precardioversion, i.e. consecutive INR values 2.0–3.0 in patients with vitamin K antagonists (VKA). We aimed to evaluate the occurrence and impact of subtherapeutic INRs precardioversion and to study factors associated with these unwanted fluctuations. Claessen, Roy oth Pisters, Ron oth Schulmer, Germaine oth Ramaekers, Roos oth Sonneveld, Laura oth Dudink, Elton oth Lankveld, Theo oth Limantoro, Ione oth Weijs, Bob oth Pison, Laurent oth Blaauw, Yuri oth de Vos, Cees B oth Crijns, Harry JGM oth Enthalten in Elsevier Science Fabersani, Emanuel ELSEVIER Metabolic effects of goat milk yogurt supplemented with yacon flour in rats on high-fat diet 2018 Amsterdam [u.a.] (DE-627)ELV000849189 volume:225 year:2016 day:15 month:12 pages:337-341 extent:5 https://doi.org/10.1016/j.ijcard.2016.10.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 225 2016 15 1215 337-341 5 045F 610 |
| spelling |
10.1016/j.ijcard.2016.10.018 doi GBVA2016006000027.pica (DE-627)ELV013904280 (ELSEVIER)S0167-5273(16)32820-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 630 640 610 VZ Erküner, Ömer verfasserin aut Poor anticoagulation relates to extended access times for cardioversion and is associated with long-term major cardiac and cerebrovascular events 2016 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Patients undergoing elective electrical cardioversion (ECV) for atrial fibrillation have a temporarily increased risk of thromboembolism. Current guidelines recommend adequate anticoagulation for ≥3 consecutive weeks precardioversion, i.e. consecutive INR values 2.0–3.0 in patients with vitamin K antagonists (VKA). We aimed to evaluate the occurrence and impact of subtherapeutic INRs precardioversion and to study factors associated with these unwanted fluctuations. Claessen, Roy oth Pisters, Ron oth Schulmer, Germaine oth Ramaekers, Roos oth Sonneveld, Laura oth Dudink, Elton oth Lankveld, Theo oth Limantoro, Ione oth Weijs, Bob oth Pison, Laurent oth Blaauw, Yuri oth de Vos, Cees B oth Crijns, Harry JGM oth Enthalten in Elsevier Science Fabersani, Emanuel ELSEVIER Metabolic effects of goat milk yogurt supplemented with yacon flour in rats on high-fat diet 2018 Amsterdam [u.a.] (DE-627)ELV000849189 volume:225 year:2016 day:15 month:12 pages:337-341 extent:5 https://doi.org/10.1016/j.ijcard.2016.10.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 225 2016 15 1215 337-341 5 045F 610 |
| allfields_unstemmed |
10.1016/j.ijcard.2016.10.018 doi GBVA2016006000027.pica (DE-627)ELV013904280 (ELSEVIER)S0167-5273(16)32820-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 630 640 610 VZ Erküner, Ömer verfasserin aut Poor anticoagulation relates to extended access times for cardioversion and is associated with long-term major cardiac and cerebrovascular events 2016 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Patients undergoing elective electrical cardioversion (ECV) for atrial fibrillation have a temporarily increased risk of thromboembolism. Current guidelines recommend adequate anticoagulation for ≥3 consecutive weeks precardioversion, i.e. consecutive INR values 2.0–3.0 in patients with vitamin K antagonists (VKA). We aimed to evaluate the occurrence and impact of subtherapeutic INRs precardioversion and to study factors associated with these unwanted fluctuations. Claessen, Roy oth Pisters, Ron oth Schulmer, Germaine oth Ramaekers, Roos oth Sonneveld, Laura oth Dudink, Elton oth Lankveld, Theo oth Limantoro, Ione oth Weijs, Bob oth Pison, Laurent oth Blaauw, Yuri oth de Vos, Cees B oth Crijns, Harry JGM oth Enthalten in Elsevier Science Fabersani, Emanuel ELSEVIER Metabolic effects of goat milk yogurt supplemented with yacon flour in rats on high-fat diet 2018 Amsterdam [u.a.] (DE-627)ELV000849189 volume:225 year:2016 day:15 month:12 pages:337-341 extent:5 https://doi.org/10.1016/j.ijcard.2016.10.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 225 2016 15 1215 337-341 5 045F 610 |
| allfieldsGer |
10.1016/j.ijcard.2016.10.018 doi GBVA2016006000027.pica (DE-627)ELV013904280 (ELSEVIER)S0167-5273(16)32820-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 630 640 610 VZ Erküner, Ömer verfasserin aut Poor anticoagulation relates to extended access times for cardioversion and is associated with long-term major cardiac and cerebrovascular events 2016 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Patients undergoing elective electrical cardioversion (ECV) for atrial fibrillation have a temporarily increased risk of thromboembolism. Current guidelines recommend adequate anticoagulation for ≥3 consecutive weeks precardioversion, i.e. consecutive INR values 2.0–3.0 in patients with vitamin K antagonists (VKA). We aimed to evaluate the occurrence and impact of subtherapeutic INRs precardioversion and to study factors associated with these unwanted fluctuations. Claessen, Roy oth Pisters, Ron oth Schulmer, Germaine oth Ramaekers, Roos oth Sonneveld, Laura oth Dudink, Elton oth Lankveld, Theo oth Limantoro, Ione oth Weijs, Bob oth Pison, Laurent oth Blaauw, Yuri oth de Vos, Cees B oth Crijns, Harry JGM oth Enthalten in Elsevier Science Fabersani, Emanuel ELSEVIER Metabolic effects of goat milk yogurt supplemented with yacon flour in rats on high-fat diet 2018 Amsterdam [u.a.] (DE-627)ELV000849189 volume:225 year:2016 day:15 month:12 pages:337-341 extent:5 https://doi.org/10.1016/j.ijcard.2016.10.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 225 2016 15 1215 337-341 5 045F 610 |
| allfieldsSound |
10.1016/j.ijcard.2016.10.018 doi GBVA2016006000027.pica (DE-627)ELV013904280 (ELSEVIER)S0167-5273(16)32820-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 630 640 610 VZ Erküner, Ömer verfasserin aut Poor anticoagulation relates to extended access times for cardioversion and is associated with long-term major cardiac and cerebrovascular events 2016 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Patients undergoing elective electrical cardioversion (ECV) for atrial fibrillation have a temporarily increased risk of thromboembolism. Current guidelines recommend adequate anticoagulation for ≥3 consecutive weeks precardioversion, i.e. consecutive INR values 2.0–3.0 in patients with vitamin K antagonists (VKA). We aimed to evaluate the occurrence and impact of subtherapeutic INRs precardioversion and to study factors associated with these unwanted fluctuations. Claessen, Roy oth Pisters, Ron oth Schulmer, Germaine oth Ramaekers, Roos oth Sonneveld, Laura oth Dudink, Elton oth Lankveld, Theo oth Limantoro, Ione oth Weijs, Bob oth Pison, Laurent oth Blaauw, Yuri oth de Vos, Cees B oth Crijns, Harry JGM oth Enthalten in Elsevier Science Fabersani, Emanuel ELSEVIER Metabolic effects of goat milk yogurt supplemented with yacon flour in rats on high-fat diet 2018 Amsterdam [u.a.] (DE-627)ELV000849189 volume:225 year:2016 day:15 month:12 pages:337-341 extent:5 https://doi.org/10.1016/j.ijcard.2016.10.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 225 2016 15 1215 337-341 5 045F 610 |
| language |
English |
| source |
Enthalten in Metabolic effects of goat milk yogurt supplemented with yacon flour in rats on high-fat diet Amsterdam [u.a.] volume:225 year:2016 day:15 month:12 pages:337-341 extent:5 |
| sourceStr |
Enthalten in Metabolic effects of goat milk yogurt supplemented with yacon flour in rats on high-fat diet Amsterdam [u.a.] volume:225 year:2016 day:15 month:12 pages:337-341 extent:5 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Metabolic effects of goat milk yogurt supplemented with yacon flour in rats on high-fat diet |
| authorswithroles_txt_mv |
Erküner, Ömer @@aut@@ Claessen, Roy @@oth@@ Pisters, Ron @@oth@@ Schulmer, Germaine @@oth@@ Ramaekers, Roos @@oth@@ Sonneveld, Laura @@oth@@ Dudink, Elton @@oth@@ Lankveld, Theo @@oth@@ Limantoro, Ione @@oth@@ Weijs, Bob @@oth@@ Pison, Laurent @@oth@@ Blaauw, Yuri @@oth@@ de Vos, Cees B @@oth@@ Crijns, Harry JGM @@oth@@ |
| publishDateDaySort_date |
2016-01-15T00:00:00Z |
| hierarchy_top_id |
ELV000849189 |
| dewey-sort |
3610 |
| id |
ELV013904280 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV013904280</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623111512.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijcard.2016.10.018</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016006000027.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV013904280</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0167-5273(16)32820-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="a">640</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Erküner, Ömer</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Poor anticoagulation relates to extended access times for cardioversion and is associated with long-term major cardiac and cerebrovascular events</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Patients undergoing elective electrical cardioversion (ECV) for atrial fibrillation have a temporarily increased risk of thromboembolism. Current guidelines recommend adequate anticoagulation for ≥3 consecutive weeks precardioversion, i.e. consecutive INR values 2.0–3.0 in patients with vitamin K antagonists (VKA). We aimed to evaluate the occurrence and impact of subtherapeutic INRs precardioversion and to study factors associated with these unwanted fluctuations.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Claessen, Roy</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pisters, Ron</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schulmer, Germaine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ramaekers, Roos</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sonneveld, Laura</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dudink, Elton</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lankveld, Theo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Limantoro, Ione</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Weijs, Bob</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pison, Laurent</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Blaauw, Yuri</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">de Vos, Cees B</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Crijns, Harry JGM</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Fabersani, Emanuel ELSEVIER</subfield><subfield code="t">Metabolic effects of goat milk yogurt supplemented with yacon flour in rats on high-fat diet</subfield><subfield code="d">2018</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000849189</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:225</subfield><subfield code="g">year:2016</subfield><subfield code="g">day:15</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:337-341</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijcard.2016.10.018</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">225</subfield><subfield code="j">2016</subfield><subfield code="b">15</subfield><subfield code="c">1215</subfield><subfield code="h">337-341</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Erküner, Ömer |
| spellingShingle |
Erküner, Ömer ddc 610 ddc 630 Poor anticoagulation relates to extended access times for cardioversion and is associated with long-term major cardiac and cerebrovascular events |
| authorStr |
Erküner, Ömer |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000849189 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 630 - Agriculture & related technologies 640 - Home & family management |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 630 640 610 VZ Poor anticoagulation relates to extended access times for cardioversion and is associated with long-term major cardiac and cerebrovascular events |
| topic |
ddc 610 ddc 630 |
| topic_unstemmed |
ddc 610 ddc 630 |
| topic_browse |
ddc 610 ddc 630 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
r c rc r p rp g s gs r r rr l s ls e d ed t l tl i l il b w bw l p lp y b yb v c b d vcb vcbd h j c hj hjc |
| hierarchy_parent_title |
Metabolic effects of goat milk yogurt supplemented with yacon flour in rats on high-fat diet |
| hierarchy_parent_id |
ELV000849189 |
| dewey-tens |
610 - Medicine & health 630 - Agriculture 640 - Home & family management |
| hierarchy_top_title |
Metabolic effects of goat milk yogurt supplemented with yacon flour in rats on high-fat diet |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000849189 |
| title |
Poor anticoagulation relates to extended access times for cardioversion and is associated with long-term major cardiac and cerebrovascular events |
| ctrlnum |
(DE-627)ELV013904280 (ELSEVIER)S0167-5273(16)32820-0 |
| title_full |
Poor anticoagulation relates to extended access times for cardioversion and is associated with long-term major cardiac and cerebrovascular events |
| author_sort |
Erküner, Ömer |
| journal |
Metabolic effects of goat milk yogurt supplemented with yacon flour in rats on high-fat diet |
| journalStr |
Metabolic effects of goat milk yogurt supplemented with yacon flour in rats on high-fat diet |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
337 |
| author_browse |
Erküner, Ömer |
| container_volume |
225 |
| physical |
5 |
| class |
610 610 DE-600 630 640 610 VZ |
| format_se |
Elektronische Aufsätze |
| author-letter |
Erküner, Ömer |
| doi_str_mv |
10.1016/j.ijcard.2016.10.018 |
| dewey-full |
610 630 640 |
| title_sort |
poor anticoagulation relates to extended access times for cardioversion and is associated with long-term major cardiac and cerebrovascular events |
| title_auth |
Poor anticoagulation relates to extended access times for cardioversion and is associated with long-term major cardiac and cerebrovascular events |
| abstract |
Patients undergoing elective electrical cardioversion (ECV) for atrial fibrillation have a temporarily increased risk of thromboembolism. Current guidelines recommend adequate anticoagulation for ≥3 consecutive weeks precardioversion, i.e. consecutive INR values 2.0–3.0 in patients with vitamin K antagonists (VKA). We aimed to evaluate the occurrence and impact of subtherapeutic INRs precardioversion and to study factors associated with these unwanted fluctuations. |
| abstractGer |
Patients undergoing elective electrical cardioversion (ECV) for atrial fibrillation have a temporarily increased risk of thromboembolism. Current guidelines recommend adequate anticoagulation for ≥3 consecutive weeks precardioversion, i.e. consecutive INR values 2.0–3.0 in patients with vitamin K antagonists (VKA). We aimed to evaluate the occurrence and impact of subtherapeutic INRs precardioversion and to study factors associated with these unwanted fluctuations. |
| abstract_unstemmed |
Patients undergoing elective electrical cardioversion (ECV) for atrial fibrillation have a temporarily increased risk of thromboembolism. Current guidelines recommend adequate anticoagulation for ≥3 consecutive weeks precardioversion, i.e. consecutive INR values 2.0–3.0 in patients with vitamin K antagonists (VKA). We aimed to evaluate the occurrence and impact of subtherapeutic INRs precardioversion and to study factors associated with these unwanted fluctuations. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
Poor anticoagulation relates to extended access times for cardioversion and is associated with long-term major cardiac and cerebrovascular events |
| url |
https://doi.org/10.1016/j.ijcard.2016.10.018 |
| remote_bool |
true |
| author2 |
Claessen, Roy Pisters, Ron Schulmer, Germaine Ramaekers, Roos Sonneveld, Laura Dudink, Elton Lankveld, Theo Limantoro, Ione Weijs, Bob Pison, Laurent Blaauw, Yuri de Vos, Cees B Crijns, Harry JGM |
| author2Str |
Claessen, Roy Pisters, Ron Schulmer, Germaine Ramaekers, Roos Sonneveld, Laura Dudink, Elton Lankveld, Theo Limantoro, Ione Weijs, Bob Pison, Laurent Blaauw, Yuri de Vos, Cees B Crijns, Harry JGM |
| ppnlink |
ELV000849189 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.ijcard.2016.10.018 |
| up_date |
2024-07-06T20:04:35.685Z |
| _version_ |
1803861387573723136 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV013904280</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623111512.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijcard.2016.10.018</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016006000027.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV013904280</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0167-5273(16)32820-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="a">640</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Erküner, Ömer</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Poor anticoagulation relates to extended access times for cardioversion and is associated with long-term major cardiac and cerebrovascular events</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Patients undergoing elective electrical cardioversion (ECV) for atrial fibrillation have a temporarily increased risk of thromboembolism. Current guidelines recommend adequate anticoagulation for ≥3 consecutive weeks precardioversion, i.e. consecutive INR values 2.0–3.0 in patients with vitamin K antagonists (VKA). We aimed to evaluate the occurrence and impact of subtherapeutic INRs precardioversion and to study factors associated with these unwanted fluctuations.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Claessen, Roy</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pisters, Ron</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schulmer, Germaine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ramaekers, Roos</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sonneveld, Laura</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dudink, Elton</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lankveld, Theo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Limantoro, Ione</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Weijs, Bob</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pison, Laurent</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Blaauw, Yuri</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">de Vos, Cees B</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Crijns, Harry JGM</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Fabersani, Emanuel ELSEVIER</subfield><subfield code="t">Metabolic effects of goat milk yogurt supplemented with yacon flour in rats on high-fat diet</subfield><subfield code="d">2018</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000849189</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:225</subfield><subfield code="g">year:2016</subfield><subfield code="g">day:15</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:337-341</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijcard.2016.10.018</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">225</subfield><subfield code="j">2016</subfield><subfield code="b">15</subfield><subfield code="c">1215</subfield><subfield code="h">337-341</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.402787 |